Prothena Corp Public (PRTA) Other Non Operating Income (2013 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Other Non Operating Income of $271000.0 in Q1 2026, up 1331.82% quarter-over-quarter from -$22000.0 in Q4 2025, and up 293.57% on a YoY basis from $68856.6 in Q1 2025.
Prothena Corp Public (PRTA) Other Non Operating Income (2013 - 2026) Analysis & Trends
Prothena Corp Public's Other Non Operating Income history runs 14 years deep, the most recent figure standing at $271000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 293.57% year-over-year to $271000.0; the TTM figure through Mar 2026 stood at $83000.0 (up 133.47% YoY), while the FY2025 annual figure was -$328000.0, down 77.3% from the prior year.
- Other Non Operating Income was $271000.0 for Q1 2026 at Prothena Corp Public, up from -$22000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $271000.0 in Q1 2026 to a low of -$327000.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged -$64529.4 across 5 years, with a median of -$66000.0 in 2024.
- The sharpest annual moves came in 2023 and 2026: Other Non Operating Income sank 4750.0% in 2023, then soared 293.57% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at -$327000.0 in 2022, then soared by 37.31% to -$205000.0 in 2023, then surged by 104.39% to $9000.0 in 2024, then plunged by 344.44% to -$22000.0 in 2025, then surged by 1331.82% to $271000.0 in 2026.
- The last three Other Non Operating Income figures came in at $271000.0 (Q1 2026), -$22000.0 (Q4 2025), and -$23000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -140,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -66,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | -77,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | -141,000.00 |
| Dec 31, 2022 | -327,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | -16,000.00 |
| Sep 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -61,000.00 |